Live
FierceBiotechEli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4EFierceBiotechAmenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grillingEndpoints NewsFDA greenlights Colorado's drug import proposalCellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMFierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375MBioPharma DiveLilly buys non-opioid pain drugmaker 4EBioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmaciesBioWorldChinese challenger Gan & Lee gains momentum in metabolic diseaseBioWorldElixiron’s enrupatinib shows upbeat interim phase II AD resultsBioWorldChina partnerships drive biopharma’s biggest deal month since 2023BioWorldOricell brings first pivotal-stage CAR T in liver cancerBioWorldLaekna licenses LAE-118 ex-China to Vasque in $527M deal
BioWorld Jan 30, 2026

Appointments and advancements for Jan. 30, 2026

Appointments and advancements for Jan. 30, 2026

Original
Body unavailable. Use the original source.